Navigation Links
Actavis and Medicines360 Announce Partnership to Advance Women's Access to Affordable IUDs
Date:6/11/2013

SAN FRANCISCO and PARSIPPANY, N.J., June 11, 2013 /PRNewswire/ -- Medicines360, a non-profit pharmaceutical company, and Actavis, Inc., a leading global specialty pharmaceutical company, today announced a historic partnership to support Medicines360's mission to reduce cost as a barrier to accessing women's birth control.  The Medicines360 and Actavis partnership will make the IUD available in the U.S. commercially and at a very low price in U.S. public sector clinics.  As part of this agreement, Actavis has licensed the U.S. commercial rights for the Medicines360 LNG20 Intrauterine Device (IUD). Medicines360 retains rights to market the product in the U.S. public sector, including family planning clinics that provide services to low-income women.  LNG20, originally developed by Uteron Pharma S.P.R.L. in Belgium, is designed to initially deliver 20 mcg of levonorgestrel per day for the indication of long term contraception, and is currently in Phase III clinical trials in the United States.  Pending U.S. Food and Drug Administration (FDA) approval, the LNG20 IUD could be launched in the U.S. as early as 2014. 

"Addressing unmet needs of underserved women is the reason Medicines360 exists," said Victoria Hale, PhD, Medicines360 Founder & CEO. "The belief that companies have to choose between serving the public sector and making money is a fallacy but we're setting out to demonstrate the ways in which this is possible. It doesn't have to be a money-losing proposition or perpetually financed through philanthropy. IUDs in general have been shown to be a very effective contraceptive, but have been too expensive for most women.  My motivation is to provide access to effective birth control options regardless of a person's income.  Actavis shares our vision of a world in which a woman's access to birth control is
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
2. Actavis, Inc. to Present at the Goldman Sachs 34th Annual Global Healthcare Conference 2013
3. The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy
4. Actavis NDA for Progestin-Only Patch Accepted for Filing by FDA
5. Actavis Cancels Presentation at Bank of America Merrill Lynch Healthcare Conference
6. Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc
7. Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
8. Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
9. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
10. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
11. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... and SAN DIEGO , July ... parent company Eisai Co., Ltd. (Headquarters: Tokyo ... "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: San ... Helen Torley , "NASDAQ: HALO") have signed a clinical ... Halaven ® , "eribulin") in combination with Halozyme,s investigational ...
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO.  "Bob has provided a valuable perspective ...
(Date:7/30/2015)... SAN DIEGO, July 30, 2015  ResMed Inc. (NYSE: ... ended June 30, 2015.  Revenue for the quarter was ... quarter ended June 30, 2014 (a 17 percent increase ... million, consistent with the quarter ended June 30, 2014. ... consistent with the quarter ended June 30, 2014.  ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... , ST. LOUIS , Feb. 3 ... of Directors declared a quarterly dividend of $0.04 ... shareholders of record on February 15, 2010 . , ... by dentists, dental hygienists, dental assistants, and consumers. The Company,s ...
... , SAN DIEGO , Feb. 3 BD ... BDX ), today announced the launch of the Be ... of influenza. Recognizing that schools and hospitals are important centers for ... designed to communicate that everyone can help prevent the spread of ...
Cached Medicine Technology:Young Innovations, Inc. Board of Directors Declares Quarterly Dividend 2BD Launches 'Be a Flu Fighter' Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories 2
(Date:7/31/2015)... Angeles, CA (PRWEB) , ... July 31, 2015 , ... ... surgeons and cosmetic experts gathered to see if they could reach a consensus on ... including breast augmentation and facelifts. Overall, the group reached 90 percent consensus on a ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and potential patients alike on various plastic surgery procedures including, but not limited ... such popular dermatology procedures like Botox and fillers. , Staying up to ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Transfinder, a software ... , Total sales were up 16 percent year-over-year for the first six months ended ... Civitella said he expected Transfinder to beat last year’s record-revenue mark of $10.4 million. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Girl Scouts of ... bullying across Georgia through the Girl Scout "Be a Friend First" program. Representatives from ... July 30. , “Peach State Health Plan and our parent company, Centene Corporation, ...
(Date:7/31/2015)... ... ... The 2015 ALS Ice Bucket Challenge will officially get underway today at ... Ice Bucket co-founders Pat Quinn and Pete Frates, the ALS community and Lou Gehrig’s ... the ALS organizations to find treatments and cures for the disease. , ALS ...
Breaking Medicine News(10 mins):Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4
... current,issue of the journal Public Health Reports examines the potential ... dental amalgam, a material,commonly used to fill cavities. The authors ... $8.2 billion in the first year alone -- a,staggering 10 ... available as a treatment option. Dental amalgam contains a ...
... dog new tricks: antimalarial prevents cancer in mice ... from St Jude Childrens Research Hospital, Memphis, and Scripps ... chloroquine effectively prevents cancer in mouse models of two ... As discussed in the accompanying commentary by Chi Dang, ...
... 20, 2007 In one of the largest studies of ... Public Health assessed the risk of exposure to bloodborne pathogens ... one out of 10 of the more than 1100 nurse ... 12 months. Findings of the study are published in ...
... the structure of a DNA-protein complex that is crucial in ... also provides fundamental insight into how cells successfully divide into ... in the Dec. 20th issue of Nature focuses on how ... Using X-ray crystallography, the team led by structural biologists at ...
... Cardiovascular disease (CVD) death rates are declining, but CVD ... the United States, and risk factor control remains a ... from the American Heart Associations Heart Disease and Stroke ... available in the Dec. 17 online issue of Circulation: ...
... One small water line feeding one hospital ... Legionella expert Janet Stout, Ph.D., urging public health and ... other waterborne microbes that contribute to soaring hospital infection ... can line every pipe in every water distribution system ...
Cached Medicine News:Health News:Banning Amalgam Could Increase U.S. Dental Costs by $8 Billion a Year 2Health News:JCI table of contents: Dec. 20, 2007 2Health News:JCI table of contents: Dec. 20, 2007 3Health News:JCI table of contents: Dec. 20, 2007 4Health News:JCI table of contents: Dec. 20, 2007 5Health News:JCI table of contents: Dec. 20, 2007 6Health News:JCI table of contents: Dec. 20, 2007 7Health News:JCI table of contents: Dec. 20, 2007 8Health News:Nonhospital health-care workers at substantial risk of exposure to bloodborne pathogens 2Health News:Nonhospital health-care workers at substantial risk of exposure to bloodborne pathogens 3Health News:Researchers solve first structure of a key to intact DNA inheritance 2Health News:Researchers solve first structure of a key to intact DNA inheritance 3Health News:Cardiovascular disease death rates decline, but risk factors still exact heavy toll 2Health News:Cardiovascular disease death rates decline, but risk factors still exact heavy toll 3Health News:Cardiovascular disease death rates decline, but risk factors still exact heavy toll 4Health News:Cardiovascular disease death rates decline, but risk factors still exact heavy toll 5Health News:Making hospitals safer from infection 2
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... complete offering of cardiology catheters. Available in ... are designed with excellent torque, new wire-braid ... push-ability, and large inner lumens for excellent ... and 7 French sizes with pressure ratings ...
Medicine Products: